Beranda › Penyakit Sel Sabit › Connecticut
Uji klinis Penyakit Sel Sabit di Connecticut
7 studi untuk Penyakit Sel Sabit mencari peserta di lokasi di Connecticut.
Kota di Connecticut
Teks studi resmi (Bahasa Inggris)
A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
- Yale-New Haven Hospital, New Haven
Menerima pesertaFase 1/2Sukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Agu 2026 · NCT06481306A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
- Connecticut Children's Medical Center, Hartford
- Smilow Cancer Hospital, New Haven
Menerima pesertaFase 2/3
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 18 Agu 2026 · NCT05431088ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Connecticut Children's Medical Center, Hartford
- Yale Hemophilia Treatment Center, New Haven
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT04398628Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
- Yale School of Medicine, New Haven
Menerima pesertaFase 1/2
1 Day – 21 Years · Semua jenis kelamin · Diperbarui 29 Mei 2026 · NCT03128996Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
- Connecticut Children's Medical Center, Hartford
Menerima peserta
Usia 16 hingga 30 · Semua jenis kelamin · Diperbarui 7 Jan 2026 · NCT06374238Integrative Training Program for Pediatric Sickle Cell Pain
- Connecticut Children's Medical Center, Hartford
Menerima peserta
Usia 12 hingga 18 · Semua jenis kelamin · Diperbarui 14 Nov 2025 · NCT06691867Bone Loss, Physical Function and Frailty in Older Women With Sickle Cell Trait Sickle Cell Trait
- UConn Health, Farmington
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 50 ke atas · Wanita · Diperbarui 24 Jul 2025 · NCT07083531Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.